权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Core C: Enzymology Core

核心 C：酶学核心

基本信息

批准号：
10513682
负责人：
CRAIG E. CAMERON
金额：
$ 746.26万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-05-16 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10513682
关键词：
Alberta province Alphavirus Bacteria Binding Sites Biochemical Biochemistry Biological Assay Biophysics COVID-19 assay Cells Collaborations Communities Complex Coronavirus Cryoelectron Microscopy Development Distant Ebola virus Enzymatic Biochemistry Enzyme Inhibition Enzyme Kinetics Enzymes Exhibits Filovirus Flavivirus Generations Goals HIV-1 Insecta International Laboratories Lead Mammalian Cell Measurement Miniaturization Monitor Multienzyme Complexes Multiprotein Complexes Mutation Nucleotides Polymerase Process Protein Family RNA Helicase RNA-Directed DNA Polymerase Records Research Project Grants Resistance Resistance development Reverse Transcriptase Inhibitors SARS coronavirus Structure System Technology Testing Translations Universities Validation Viral Virus X-Ray Crystallography antiviral drug development biophysical techniques density drug development drug discovery high throughput screening inhibitor insight interest lead optimization member programs protein expression protein purification protocol development screening single molecule structural biology three dimensional structure tool virology

项目摘要

ABSTRACT The overarching goal of Core C is to support READDI-AC discovery efforts in collaboration with Discovery Core B and MedChem Core D by validation, characterization, and optimization of compounds in enzyme assays and structural studies, and to provide the Research Projects with detailed mechanisms of action and mechanistic insights to mitigate potential problems with resistance conferring mutations. Enzymology Core C includes seven internationally recognized laboratories that cover complementary expertise at the interfaces of virology, biochemistry, biophysics and structural biology. Three specific aims that describe the central activities of Enzymology Core C: Aim 1: Develop assays to support hit discovery efforts by Discovery Core B. Key activities include the expression and purification of enzymes that the Research Projects and Discovery Core B have selected as targets. Enzymology Core C will support the development of protocols for the expression and purification of new enzyme targets and their corresponding assays to monitor activity and inhibition. The translation of enzyme assays into high density formats to facilitate high throughput screening by Discovery Core B is a second responsibility. Aim 2. Structural Biology to guide hit and lead optimization. Enzymology Core C will focus on solving 3D structures of polymerases and RNA helicases that are currently not available to the scientific community. Priority will also be given to solving the structures of flavivirus and alphavirus polymerases in complex with the nucleotide and non-nucleotide analog inhibitors to provide detailed information on the inhibitor binding sites. Aim 3. Support the Projects in detailed mechanism of action studies for lead compounds. Functional assays will be employed to assess the inhibitory activity against the biologically relevant enzyme target, such as measurements of the half maximal inhibitory concentration to determine compound potency. Promising hits and leads will also be tested against homologous enzymes within the protein family as well as distant enzymes to assess breadth and the potential for off-target activity. Enzymology Core C will provide an array of state-of-the-art biochemical/biophysical approaches to provide MedChem Core D and the Projects with information on the mechanisms associated with inhibition and resistance.

摘要